Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Veracyte (VCYT) has a market cap of $3.34 billion USD. According to our data, Veracyte is ranked No.3319 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $3.34 B |
8.71%
|
| Dec 31, 2024 | $3.07 B |
43.95%
|
| Dec 29, 2023 | $2.13 B |
15.93%
|
| Dec 30, 2022 | $1.84 B |
-42.40%
|
| Dec 31, 2021 | $3.19 B |
-15.82%
|
| Dec 31, 2020 | $3.79 B |
75.29%
|
| Dec 31, 2019 | $2.16 B |
121.94%
|
| Dec 31, 2018 | $0.97 B |
92.65%
|
| Dec 29, 2017 | $0.51 B |
-15.63%
|
| Dec 30, 2016 | $0.60 B |
7.50%
|
| Dec 31, 2015 | $0.56 B |
-25.47%
|
| Dec 31, 2014 | $0.75 B |
-33.38%
|
| Dec 31, 2013 | $1.12 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Exact Sciences
EXAS
|
$10.14 B |
0.000 M
|
USA
|
 Natera
NTRA
|
$22.70 B |
-0.001 M
|
USA
|
 Guardant Health
GH
|
$5.83 B |
0.000 M
|
USA
|
 Adaptive Biotechnologies
ADPT
|
$1.18 B |
0.000 M
|
USA
|
 NeoGenomics
NEO
|
$1.86 B |
0.000 M
|
USA
|
 Myriad Genetics
MYGN
|
$1.12 B |
-0.000 M
|
USA
|
 CareDx
CDNA
|
$1.24 B |
-0.000 M
|
USA
|
 Personalis
PSNL
|
$0.47 B |
0.000 M
|
USA
|
 Fulgent Genetics
FLGT
|
$0.52 B |
-0.000 M
|
USA
|
 OncoCyte
OCX
|
$33.00 M |
0.000 M
|
USA
|
 Pacific Biosciences
PACB
|
$0.53 B |
-0.000 M
|
USA
|
| Market Cap | = | VCYT Stock Price | * | VCYT Shares Outstanding |
| = | $43.05 | * | 77.50 M | |
| = | $3.34 B |